These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased mortality associated with elevated carcinoembryonic antigen in insurance applicants. Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L J Insur Med; 2007; 39(4):251-8. PubMed ID: 18522142 [TBL] [Abstract][Full Text] [Related]
3. Proteinuria as a mortality risk. Duddleston DN J Insur Med; 2004; 36(3):262-6. PubMed ID: 15495442 [TBL] [Abstract][Full Text] [Related]
4. Principles of insurance and actuarial science. Holland DM Trans Assoc Life Insur Med Dir Am; 1992; 75():21-8. PubMed ID: 1494839 [No Abstract] [Full Text] [Related]
6. [Increased carcinoembryonic antigen: what is the diagnosis?]. Gärtner H; Maier KP Dtsch Med Wochenschr; 2005 Oct; Suppl 1():95. PubMed ID: 16379259 [No Abstract] [Full Text] [Related]
7. The gang of four: how does the growth of life settlements affect the life insurance industry? Nowlan WJ J Insur Med; 2007; 39(1):28-32. PubMed ID: 17500354 [No Abstract] [Full Text] [Related]
8. [Risk determination and risk adjustment for life insurance]. Raestrup O Ther Ggw; 1981 Aug; 120(8):739-47. PubMed ID: 7292359 [No Abstract] [Full Text] [Related]
9. [Scientific approach to prognosis in medicine]. Pestel M Bull Acad Natl Med; 1983 Apr; 167(4):291-5. PubMed ID: 6354373 [No Abstract] [Full Text] [Related]
10. Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage? Kawachi R; Nakazato Y; Takei H; Koshi-ishi Y; Goya T Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):199-202. PubMed ID: 19457896 [TBL] [Abstract][Full Text] [Related]
11. [Use of determination of the serum carcinoembryonic antigen in oncopulmonology]. Lazarev SM; Reshetov AV; Nikolaev GV; Volgin GN; Nokhrin AV; Kokorin DM Vestn Khir Im I I Grek; 2009; 168(3):21-5. PubMed ID: 19663274 [TBL] [Abstract][Full Text] [Related]
12. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327 [TBL] [Abstract][Full Text] [Related]
13. Conversion of mortality ratios to a numerical rating classification for life insurance underwriting. 1988. Singer RB J Insur Med; 2004; 36(3):234-41. PubMed ID: 15495439 [No Abstract] [Full Text] [Related]
14. Preparation of mortality abstracts. Ivanovic B J Insur Med; 2004; 36(2):115-8. PubMed ID: 15384231 [No Abstract] [Full Text] [Related]
15. Re: Ho et al.: Primary mucinous adenocarcinoma of renal pelvis with carcinoembryonic antigen production. (Urology 2008;71:e7-e8). Ho CH; Chou CY; Yu HJ; Huang CY Urology; 2009 Aug; 74(2):475. PubMed ID: 19646634 [No Abstract] [Full Text] [Related]
16. A breath of fresh air for COPD. Quartararo P J Insur Med; 2008; 40(1):20-5. PubMed ID: 18924363 [No Abstract] [Full Text] [Related]
17. Morbidity, mortality, and the C-2 risk. Cowell M J Insur Med; 1994; 26(3):313-6. PubMed ID: 10150505 [No Abstract] [Full Text] [Related]
18. Anatomy of an abstract. Kita MW J Insur Med; 2004; 36(2):130-1. PubMed ID: 15384235 [No Abstract] [Full Text] [Related]
19. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study. Oussoultzoglou E; Rosso E; Fuchshuber P; Stefanescu V; Diop B; Giraudo G; Pessaux P; Bachellier P; Jaeck D Arch Surg; 2008 Dec; 143(12):1150-8; discussion 1158-9. PubMed ID: 19075165 [TBL] [Abstract][Full Text] [Related]
20. Comparison of body mass index and waist circumference as predictors of all-cause mortality in a male insured lives population. Cumming ME; Pinkham CA J Insur Med; 2008; 40(1):26-33. PubMed ID: 18924364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]